|
US4777964A
(en)
|
1986-01-02 |
1988-10-18 |
David Briggs |
System for obtaining blood samples and submitting for testing of aids
|
|
US5096830A
(en)
|
1987-11-17 |
1992-03-17 |
Adeza Biomedical Corporation |
Preterm labor and membrane rupture test
|
|
US5223440A
(en)
|
1987-11-17 |
1993-06-29 |
Adeza Biomedical Corporation |
Ex vivo product of conception test to determine abortion
|
|
US4919889A
(en)
|
1988-09-15 |
1990-04-24 |
Aspen Diagnostics Corporation |
Sample collection and transport fluid composition
|
|
US5281522A
(en)
|
1988-09-15 |
1994-01-25 |
Adeza Biomedical Corporation |
Reagents and kits for determination of fetal fibronectin in a vaginal sample
|
|
DE69231636T2
(de)
|
1991-11-04 |
2001-05-23 |
Adeza Biomedical Corp |
Screeningverfahren zur identifizierung von frauen mit erhöhtem frühgeburtsrisiko
|
|
WO1993009432A1
(en)
|
1991-11-04 |
1993-05-13 |
Adeza Biomedical Corporation |
Screening method for identifying women at increased risk for imminent delivery
|
|
US5516702A
(en)
|
1991-11-06 |
1996-05-14 |
Adeza Biomedical Corporation |
Screening method for identifying women at increased risk for imminent delivery
|
|
CA2133967A1
(en)
|
1993-02-24 |
1994-09-01 |
Spencer H. Lin |
Immobilization of specific binding assay reagents
|
|
US5898005A
(en)
|
1993-02-24 |
1999-04-27 |
Dade Behring Inc. |
Rapid detection of analytes with receptors immobilized on soluble submicron particles
|
|
EP0689552B1
(en)
|
1993-03-23 |
2002-10-30 |
VOROTELIAK, Victor |
A method of detecting rupture of the amniotic membranes in pregant mammals
|
|
US5431171A
(en)
|
1993-06-25 |
1995-07-11 |
The Regents Of The University Of California |
Monitoring fetal characteristics by radiotelemetric transmission
|
|
WO1995006877A1
(en)
|
1993-09-03 |
1995-03-09 |
Behringwerke Ag |
Fluorescent oxygen channeling immunoassays
|
|
US5650394A
(en)
|
1993-11-04 |
1997-07-22 |
Adeza Biomedical |
Use of urinastatin-like compounds to prevent premature delivery
|
|
US5597700A
(en)
|
1994-04-28 |
1997-01-28 |
California Research, Llc |
Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
|
|
US6140099A
(en)
|
1994-05-20 |
2000-10-31 |
The Trustees Of The University Of Pennsylvania |
Method of delaying fetal membrane rupture by inhibiting matrix metalloproteinase-9 activity
|
|
US5641636A
(en)
|
1994-05-20 |
1997-06-24 |
University Of Pennsylvania |
Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity
|
|
JP3064015B2
(ja)
|
1995-01-26 |
2000-07-12 |
メルク フロスト カナダ アンド カンパニー |
プロスタグランジンレセプターｄｐ
|
|
AU706833B2
(en)
|
1995-10-31 |
1999-06-24 |
Maruha Nichiro Corporation |
A prostaglandin D synthase-specific monoclonal antibody
|
|
US6678669B2
(en)
|
1996-02-09 |
2004-01-13 |
Adeza Biomedical Corporation |
Method for selecting medical and biochemical diagnostic tests using neural network-related applications
|
|
US6544193B2
(en)
|
1996-09-04 |
2003-04-08 |
Marcio Marc Abreu |
Noninvasive measurement of chemical substances
|
|
US6120460A
(en)
|
1996-09-04 |
2000-09-19 |
Abreu; Marcio Marc |
Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions
|
|
FI963989L
(fi)
|
1996-10-04 |
1998-04-05 |
Wallac Oy |
Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon
|
|
WO1998040747A1
(en)
|
1997-03-07 |
1998-09-17 |
Mount Sinai Hospital Corporation |
Methods to diagnose a required regulation of trophoblast invasion
|
|
US6610480B1
(en)
|
1997-11-10 |
2003-08-26 |
Genentech, Inc. |
Treatment and diagnosis of cardiac hypertrophy
|
|
US6875567B1
(en)
|
1997-11-10 |
2005-04-05 |
Genentech, Inc. |
Method of detecting cardiac hypertrophy through probe hybridization and gene expression analysis
|
|
US20020031513A1
(en)
|
1997-11-24 |
2002-03-14 |
Shamir Leibovitz |
Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
|
|
US6267722B1
(en)
|
1998-02-03 |
2001-07-31 |
Adeza Biomedical Corporation |
Point of care diagnostic systems
|
|
US6394952B1
(en)
|
1998-02-03 |
2002-05-28 |
Adeza Biomedical Corporation |
Point of care diagnostic systems
|
|
US6506789B2
(en)
|
1998-06-03 |
2003-01-14 |
Shionogi & Co., Ltd. |
Methods for the treatment of itching comprising administering PGD2 receptor antagonist
|
|
US6126597A
(en)
|
1998-07-22 |
2000-10-03 |
Smith; Ramada S. |
System for identifying premature rupture of membrane during pregnancy
|
|
US6149590A
(en)
|
1998-07-22 |
2000-11-21 |
Smith; Ramada S. |
System for identifying premature rupture of membrane during pregnancy
|
|
US20010025140A1
(en)
|
1998-07-22 |
2001-09-27 |
Torok Brian A. |
System for identifying premature rupture of membrane during pregnancy
|
|
US7109044B1
(en)
|
1998-09-04 |
2006-09-19 |
Maruha Corporation |
Method of detection and disease state management for renal diseases
|
|
PL347508A1
(en)
|
1998-10-29 |
2002-04-08 |
Regents Board Of |
Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation
|
|
JP2000249709A
(ja)
|
1999-02-26 |
2000-09-14 |
Maruha Corp |
冠血管インターベンション施行後の再狭窄の予測方法
|
|
US6126616A
(en)
|
1999-06-21 |
2000-10-03 |
Sanyal; Mrinal K. |
Collection of biological products from human accessory reproductive organs by absorbent systems
|
|
ATE315230T1
(de)
|
1999-08-23 |
2006-02-15 |
Bml Inc |
Verfahren zum identifizieren von prostaglandin d2 rezeptor modulatoren
|
|
FR2809182B1
(fr)
|
2000-05-18 |
2003-08-15 |
Univ Rene Descartes |
Detection de l'il-6 pour la prevision des risques d'accouchement premature
|
|
US20010053876A1
(en)
|
2000-06-15 |
2001-12-20 |
Torok Brian A. |
System for identifying premature rupture of membrane during pregnancy
|
|
US6878522B2
(en)
|
2000-07-07 |
2005-04-12 |
Baiyong Li |
Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
|
|
WO2002008756A1
(en)
|
2000-07-21 |
2002-01-31 |
Maruha Corporation |
Method of differentiating dementing diseases
|
|
US6410583B1
(en)
|
2000-07-25 |
2002-06-25 |
Merck Frosst Canada & Co. |
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
|
|
US20020046054A1
(en)
|
2000-08-28 |
2002-04-18 |
Morand Patrick G. |
Use of blood and plasma donor samples and data in the drug discovery process
|
|
US7217725B2
(en)
|
2000-09-14 |
2007-05-15 |
Allergan, Inc. |
Prostaglandin D2 antagonist
|
|
WO2002032958A2
(en)
|
2000-10-16 |
2002-04-25 |
Bayer Aktiengesellschaft |
Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
|
|
US7635571B2
(en)
|
2000-12-07 |
2009-12-22 |
Siemens Healthcare Diagnostics Products Gmbh |
Amplified signal in binding assays
|
|
DE60215000T2
(de)
|
2001-05-23 |
2007-08-09 |
Merck Frosst Canada & Co, Kirkland |
Dihydropyrroloil[1,2-a]indol- und Tetrahydropyridol[1,2-a]indol-Derivate als Prostaglandin-D2-Rezeptor-Antagonisten
|
|
WO2003008978A2
(en)
|
2001-07-18 |
2003-01-30 |
Merck Frosst Canada & Co. |
Eosinophil prostaglandin d2 receptor assays
|
|
US20040197834A1
(en)
|
2001-07-20 |
2004-10-07 |
Francois Gervais |
Method to increase expression of pgd2 receptors and assays for identifying modulators of prostaglandin d2 receptors
|
|
US20050101841A9
(en)
|
2001-12-04 |
2005-05-12 |
Kimberly-Clark Worldwide, Inc. |
Healthcare networks with biosensors
|
|
EP1540341A4
(en)
|
2002-07-01 |
2007-01-10 |
Univ Rochester Medical Ct |
METHOD FOR DETERMINING THE PROBABILITY OF PREPARING EASY WOMEN IN PREGNANT WOMEN
|
|
JP5650876B2
(ja)
|
2002-07-19 |
2015-01-07 |
ベス・イスラエル・ディーコニス・メディカル・センター |
子癇前症または子癇の診断方法および治療方法
|
|
US7435419B2
(en)
|
2002-07-19 |
2008-10-14 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating pre-eclampsia or eclampsia
|
|
EP2204654B1
(en)
|
2002-08-13 |
2012-12-12 |
N-Dia, Inc. |
Use of devices and methods for detecting amniotic fluid in vaginal secretions
|
|
ATE483980T1
(de)
|
2002-08-29 |
2010-10-15 |
Diagnostic Technologies Ltd |
Verfahren zur diagnose von schwangerschaftsstörungen
|
|
AU2003242485A1
(en)
|
2002-09-30 |
2004-04-23 |
Shionogi And Co., Ltd. |
Novel uses of prostaglandin d2, prostaglandin d2 agonist and prostaglandin d2 antagonist
|
|
WO2004037206A2
(en)
|
2002-10-23 |
2004-05-06 |
University Of Hawaii |
Methods for diagnosing and treating pre-term labor
|
|
US20040100376A1
(en)
|
2002-11-26 |
2004-05-27 |
Kimberly-Clark Worldwide, Inc. |
Healthcare monitoring system
|
|
AU2003290773A1
(en)
|
2003-02-05 |
2004-09-06 |
Ciphergen Biosystems, Inc. |
Non-invasive assessment of intra-amniotic environment
|
|
EP1936376B1
(en)
|
2003-02-06 |
2012-04-11 |
Hologic Inc. |
Screening and treatment methods for prevention of preterm delivery
|
|
US8068990B2
(en)
|
2003-03-25 |
2011-11-29 |
Hologic, Inc. |
Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
|
|
US7191068B2
(en)
|
2003-03-25 |
2007-03-13 |
Proteogenix, Inc. |
Proteomic analysis of biological fluids
|
|
US8003765B2
(en)
|
2003-04-09 |
2011-08-23 |
Stony Brook Anaesthesiology, University Faculty Practice Corporation |
Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
|
|
US20070003992A1
(en)
|
2003-04-09 |
2007-01-04 |
Pentyala Srinivas N |
Methods and kits for detecting cerebrospinal fluid in a sample
|
|
US20040203079A1
(en)
|
2003-04-09 |
2004-10-14 |
Research Foundation Of The State University Of New York |
Methods and kits for detecting cerebrospinal fluid in a sample
|
|
US8060195B2
(en)
|
2003-05-02 |
2011-11-15 |
The Johns Hopkins University |
Devices, systems and methods for bioimpedance measurement of cervical tissue and methods for diagnosis and treatment of human cervix
|
|
JP2006528938A
(ja)
|
2003-05-20 |
2006-12-28 |
メルク フロスト カナダ リミテツド |
フルオロ−メタンスルホニル置換シクロアルカノインドール、およびプロスタグランジンｄ２アンタゴニストとしてのこれらの使用
|
|
WO2005007223A2
(en)
|
2003-07-16 |
2005-01-27 |
Sasha John |
Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
|
|
JP3897117B2
(ja)
|
2003-09-24 |
2007-03-22 |
マルハ株式会社 |
妊娠中毒症の重症度判定と予知方法、および妊娠中毒症における胎児・胎盤機能の評価方法
|
|
WO2005031360A1
(ja)
|
2003-09-26 |
2005-04-07 |
Maruha Corporation |
関節リウマチの検出又は鑑別方法及び病期又は機能障害度の判別方法
|
|
US20050131287A1
(en)
|
2003-12-16 |
2005-06-16 |
Kimberly-Clark Worldwide, Inc. |
Detection of premature rupture of the amniotic membrane
|
|
US20060024722A1
(en)
|
2004-07-30 |
2006-02-02 |
Mark Fischer-Colbrie |
Samples for detection of oncofetal fibronectin and uses thereof
|
|
US20080090759A1
(en)
|
2004-08-30 |
2008-04-17 |
Robert Kokenyesi |
Methods and kits for predicting risk for preterm labor
|
|
WO2006026557A2
(en)
|
2004-08-30 |
2006-03-09 |
Cervimark, Llc |
Methods and kits for predicting risk for peterm labor
|
|
JP5270161B2
(ja)
|
2004-09-24 |
2013-08-21 |
ベス イスラエル デアコネス メディカル センター |
妊娠合併症を診断および処置する方法
|
|
GB0422057D0
(en)
|
2004-10-05 |
2004-11-03 |
Astrazeneca Ab |
Novel compounds
|
|
HN2005000795A
(es)
|
2004-10-15 |
2010-08-19 |
Aventis Pharma Inc |
Pirimidinas como antagonistas del receptor de prostaglandina d2
|
|
EP1839056B1
(en)
|
2004-12-21 |
2011-08-03 |
Yale University |
Diagnosis of preeclampsia
|
|
CA2528531A1
(en)
|
2005-01-06 |
2006-07-06 |
Mount Sinai Hospital |
Markers of pre-term labor
|
|
DOP2006000016A
(es)
|
2005-01-26 |
2006-07-31 |
Aventis Pharma Inc |
2-fenil-indoles como antagonistas del receptor de la prostaglandina d2.
|
|
GB0505048D0
(en)
|
2005-03-11 |
2005-04-20 |
Oxagen Ltd |
Compounds with PGD antagonist activity
|
|
AU2006226891A1
(en)
*
|
2005-03-24 |
2006-09-28 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
|
|
EP1910555A2
(en)
|
2005-07-13 |
2008-04-16 |
ECI Biotech Inc. |
Substrates, sensors, and methods for assessing conditions in females
|
|
EP1911759A4
(en)
|
2005-07-22 |
2010-07-21 |
Shionogi & Co |
AZAINDOL DERIVATIVE ANTAGONISTIC EFFECT ON PGD2 RECEPTOR
|
|
US7863007B2
(en)
|
2005-09-15 |
2011-01-04 |
Swiss Asian Property Limited |
Marker for prolonged rupture of membranes
|
|
GT200600457A
(es)
|
2005-10-13 |
2007-04-27 |
Aventis Pharma Inc |
Sal de fosfato dihidrogeno como antagonistas del receptor de prostaglandina d2
|
|
US8076315B2
(en)
|
2005-10-14 |
2011-12-13 |
The Board Of Trustees Of The University Of Illinois |
Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists
|
|
US20070111326A1
(en)
|
2005-11-14 |
2007-05-17 |
Abbott Laboratories |
Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
|
|
US20080009552A1
(en)
|
2006-03-23 |
2008-01-10 |
Craig Pennell |
Markers of pre-term labor
|
|
DOP2007000068A
(es)
|
2006-04-12 |
2007-10-31 |
Sanofi Aventis Us Llc |
Compuestos de amino-pirimidina 2,6-sustituidos-4-monosustituidos como antagonistas del receptor de prostaglandina d2
|
|
HUE030850T2
(en)
|
2006-06-16 |
2017-06-28 |
Univ Pennsylvania |
Prostaglandin D2 receptor antagonists for the treatment of hair loss
|
|
KR20090039735A
(ko)
|
2006-07-25 |
2009-04-22 |
사노피-아벤티스 |
프로스타글란딘 ｄ2 수용체 길항제로서의 2-페닐-인돌
|
|
US8133859B2
(en)
|
2006-09-27 |
2012-03-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
SCGB3A2 as a growth factor and anti-apoptotic agent
|
|
CN101553254A
(zh)
|
2006-10-03 |
2009-10-07 |
建新公司 |
TGF-β拮抗物治疗具有罹患支气管肺发育不良风险的婴儿的用途
|
|
WO2008073491A1
(en)
|
2006-12-11 |
2008-06-19 |
University Of Florida Research Foundation, Inc. |
System and method for analyzing progress of labor and preterm labor
|
|
JP2010513458A
(ja)
|
2006-12-19 |
2010-04-30 |
ファイザー・プロダクツ・インク |
Ｈ−ｐｇｄｓの阻害剤としてのニコチンアミド誘導体、およびプロスタグランジンｄ２の仲介による疾患を治療するためのその使用
|
|
KR20090115930A
(ko)
|
2006-12-26 |
2009-11-10 |
브라이엄 영 유니버시티 |
혈청 단백질체학 시스템 및 관련 방법
|
|
CA2679198C
(en)
|
2007-02-26 |
2011-07-12 |
Pfizer Products Inc. |
Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
|
|
US20090058072A1
(en)
|
2007-08-30 |
2009-03-05 |
Shirlee Ann Weber |
Record sheets with integrated themes
|
|
US20100251394A1
(en)
|
2007-09-20 |
2010-09-30 |
The Johns Hopkins University |
Treatment and prevention of ischemic brain injury
|
|
WO2009059259A2
(en)
|
2007-10-31 |
2009-05-07 |
Children's Hospital Medical Center |
Detection of worsening renal disease in subjects with systemic lupus erythematosus
|
|
US20110002866A1
(en)
|
2007-10-31 |
2011-01-06 |
Lubit Beverly W |
Methods to prevent a hair-related side effect of treatment with a chemotherapeutic agent
|
|
WO2009061681A2
(en)
|
2007-11-06 |
2009-05-14 |
Amira Pharmaceuticals, Inc |
Antagonists of pgd2 receptors
|
|
US20130177485A1
(en)
|
2007-11-27 |
2013-07-11 |
Momtec Life Ltd. Of Yazmot Haemek |
Diagnostic device for identifying rupture of membrane during pregnancy
|
|
US20110065139A1
(en)
|
2007-11-27 |
2011-03-17 |
Jacob Mullerad |
diagnostic device for identifying rupture of membrane during pregnancy
|
|
JP5327762B2
(ja)
|
2007-12-14 |
2013-10-30 |
プルマジェン セラピューティクス（アズマ）リミテッド |
インドールおよびその治療的使用
|
|
RU2010133157A
(ru)
|
2008-01-07 |
2012-02-20 |
Орто-Клиникал Дайэгностикс, Инк. (Us) |
Определение комплекса sflt-1:ангиогенный фактор
|
|
US20110060026A1
(en)
|
2008-01-18 |
2011-03-10 |
George Hynd |
Indoles Active on CRTH2 Receptor
|
|
EP2657697B1
(en)
|
2008-01-25 |
2016-06-08 |
Wallac Oy |
Methods for determining the risk of chromosomal abnormality in a fetus
|
|
WO2009097579A1
(en)
|
2008-01-30 |
2009-08-06 |
Proteogenix, Inc. |
Gestational age dependent proteomic changes of human maternal serum for monitoring maternal and fetal health
|
|
WO2009097584A1
(en)
|
2008-01-30 |
2009-08-06 |
Proteogenix, Inc. |
Maternal serum biomarkers for detection of pre-eclampsia
|
|
US8067445B2
(en)
|
2008-02-01 |
2011-11-29 |
Panmira Pharmaceuticals, Llc |
N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
|
|
EP2245002A4
(en)
|
2008-02-01 |
2011-08-17 |
Amira Pharmaceuticals Inc |
AMINOALKYLBIPHENYL ANTAGONISTS N, N 'DISUBSTITUTED FROM D2 RECEPTORS OF PROSTAGLANDIN
|
|
EP2257536A4
(en)
|
2008-02-14 |
2011-03-23 |
Amira Pharmaceuticals Inc |
CYCLIC DIARYL ETHERS AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
|
|
US8497381B2
(en)
|
2008-02-25 |
2013-07-30 |
Panmira Pharmaceuticals, Llc |
Antagonists of prostaglandin D2 receptors
|
|
US8426449B2
(en)
|
2008-04-02 |
2013-04-23 |
Panmira Pharmaceuticals, Llc |
Aminoalkylphenyl antagonists of prostaglandin D2 receptors
|
|
US20110112134A1
(en)
|
2008-05-16 |
2011-05-12 |
Amira Pharmaceuticals, Inc. |
Tricyclic Antagonists of Prostaglandin D2 Receptors
|
|
CN102026650A
(zh)
|
2008-05-16 |
2011-04-20 |
科尔泰拉公司 |
预防早产的方法
|
|
EP2300425A4
(en)
|
2008-06-24 |
2012-03-21 |
Panmira Pharmaceuticals Llc |
PROSTAGLANDIN D2 RECEPTOR CYCLOALCANEÝBINDLUCK ANTAGONISTS
|
|
MX2010014172A
(es)
|
2008-07-03 |
2011-02-22 |
Amira Pharmaceuticals Inc |
Antagonistas de receptores de prostaglandina d2.
|
|
FR2934681B1
(fr)
|
2008-07-29 |
2011-09-30 |
Bastien Karkouche |
Dispositif pour la capture de particules biologiques et utilisation.
|
|
CA2735525A1
(en)
|
2008-08-04 |
2010-02-11 |
The Board Of Regents Of The University Of Texas System |
Multiplexed diagnostic test for preterm labor
|
|
MY154000A
(en)
|
2008-09-22 |
2015-04-30 |
Cayman Chem Co |
Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
|
|
GB2463788B
(en)
|
2008-09-29 |
2010-12-15 |
Amira Pharmaceuticals Inc |
Heteroaryl antagonists of prostaglandin D2 receptors
|
|
WO2010039977A2
(en)
|
2008-10-01 |
2010-04-08 |
Amira Pharmaceuticals, Inc. |
Heteroaryl antagonists of prostaglandin d2 receptors
|
|
US8524748B2
(en)
|
2008-10-08 |
2013-09-03 |
Panmira Pharmaceuticals, Llc |
Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors
|
|
GB2465062B
(en)
|
2008-11-06 |
2011-04-13 |
Amira Pharmaceuticals Inc |
Cycloalkane(B)azaindole antagonists of prostaglandin D2 receptors
|
|
US8383654B2
(en)
|
2008-11-17 |
2013-02-26 |
Panmira Pharmaceuticals, Llc |
Heterocyclic antagonists of prostaglandin D2 receptors
|
|
US9180114B2
(en)
|
2008-11-26 |
2015-11-10 |
President And Fellows Of Harvard College |
Neurodegenerative diseases and methods of modeling
|
|
US20120004233A1
(en)
|
2009-01-26 |
2012-01-05 |
Amira Pharmaceuticals, Inc |
Tricyclic compounds as antagonists of prostaglandin d2 receptors
|
|
US20120046261A1
(en)
|
2009-02-27 |
2012-02-23 |
University Of Utah Research Foundation |
Compositions and methods for diagnosing and preventing spontaneous preterm birth
|
|
GB0905964D0
(en)
|
2009-04-06 |
2009-05-20 |
King S College London |
Marker
|
|
KR20120047273A
(ko)
|
2009-08-05 |
2012-05-11 |
판미라 파마슈티칼스, 엘엘씨 |
Ｄｐ2 길항제 및 이의 용도
|
|
US20110090048A1
(en)
|
2009-09-29 |
2011-04-21 |
Li Conan K |
Data Transmission Device with User Identification Capability
|
|
CA2779270A1
(en)
|
2009-10-29 |
2011-05-05 |
The Trustees Of The University Of Pennsylvania |
Method of predicting risk of preterm birth
|
|
CA2778838A1
(en)
|
2009-11-12 |
2011-05-19 |
Cervilenz Inc. |
Devices and methods for cervix measurement
|
|
WO2011065976A1
(en)
|
2009-11-25 |
2011-06-03 |
Hologic, Inc. |
Detection of intraamniotic infection
|
|
CA2807050C
(en)
|
2009-12-08 |
2019-06-18 |
Ozlem Equils |
Diagnostic biomarker to identify women at risk for preterm delivery
|
|
US8874183B2
(en)
|
2010-02-18 |
2014-10-28 |
The Johns Hopkins University |
Preterm labor monitor
|
|
CA2793223A1
(en)
|
2010-03-16 |
2011-09-22 |
Aventis Pharmaceuticals Inc. |
Substituted pyrimidines as prostaglandin d2 receptor antagonists
|
|
MX2012010038A
(es)
|
2010-03-16 |
2012-10-01 |
Aventis Pharma Inc |
Una pirimidina sustituida como un antagonista del receptor de la prostaglandina d2.
|
|
MX2012010820A
(es)
|
2010-03-22 |
2012-10-10 |
Actelion Pharmaceuticals Ltd |
Derivados de 3-(heteroaril-amino)-1, 2, 3, 4-tetrahidro-9h-carbazo l y sus uso como moduladores del receptor de prostaglandina d2.
|
|
WO2011119757A2
(en)
|
2010-03-23 |
2011-09-29 |
The Reproductive Research Technologies, Lp |
Noninvasive measurement of uterine emg propagation and power spectrum frequency to predict true preterm labor and delivery
|
|
CN103038645B
(zh)
*
|
2010-04-13 |
2016-05-04 |
迈卡蒂斯股份有限公司 |
用于妊娠的高血压疾病的生物标志物
|
|
CA2799227C
(en)
*
|
2010-05-14 |
2020-06-16 |
Beth Israel Deaconess Medical Center, Inc. |
Extracorporeal devices and methods of treating complications of pregnancy
|
|
US20110312928A1
(en)
|
2010-06-18 |
2011-12-22 |
Lipocine Inc. |
Progesterone Containing Oral Dosage Forms and Related Methods
|
|
US20110312927A1
(en)
|
2010-06-18 |
2011-12-22 |
Satish Kumar Nachaegari |
Progesterone Containing Oral Dosage Forms and Related Methods
|
|
WO2011163554A2
(en)
|
2010-06-25 |
2011-12-29 |
Winthrop-University Hospital |
Lipocalin-type prostaglandin d2 synthase as a biomarker for lung cancer progression and prognosis
|
|
CA2805452C
(en)
|
2010-07-05 |
2018-07-31 |
Actelion Pharmaceuticals Ltd |
1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
|
|
EP2592992A4
(en)
|
2010-07-12 |
2014-04-23 |
Therasyn Sensors Inc |
DEVICE AND METHOD FOR IN VIVO MONITORING OF PATIENTS
|
|
US8765487B2
(en)
|
2010-09-01 |
2014-07-01 |
Clinical Innovations |
Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes
|
|
CN103201628B
(zh)
|
2010-10-01 |
2015-09-16 |
霍罗杰克股份有限公司 |
用于诊断系统中使用的免疫测定测试条
|
|
WO2012049316A1
(en)
|
2010-10-15 |
2012-04-19 |
Olink Ab |
Dynamic range methods
|
|
CA2819886A1
(en)
|
2010-12-06 |
2012-06-14 |
Pronota N.V. |
Biomarkers and parameters for hypertensive disorders of pregnancy
|
|
EP2670868A4
(en)
|
2011-01-31 |
2015-05-06 |
Esoterix Genetic Lab Llc |
PROCESS FOR ENRICHING MICROPARTICLES OR NUCLEIC ACIDS BY MEANS OF BONDING MOLECULES
|
|
GB201101621D0
(en)
|
2011-01-31 |
2011-03-16 |
Olink Ab |
Method and product
|
|
US8951996B2
(en)
|
2011-07-28 |
2015-02-10 |
Lipocine Inc. |
17-hydroxyprogesterone ester-containing oral compositions and related methods
|
|
EP2776839B1
(en)
|
2011-11-09 |
2017-08-30 |
Roche Diagnostics GmbH |
Dynamic of sflt-1 or endoglin/plgf ratio as an indicator for imminent preeclampsia and/or hellp syndrome
|
|
EP2812698B1
(en)
|
2012-02-06 |
2020-10-28 |
PerkinElmer Health Sciences Canada, Inc. |
Dual-acceptor time-resolved-fret
|
|
WO2013169751A1
(en)
|
2012-05-08 |
2013-11-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for providing a preeclampsia assessment
|
|
SG11201407667UA
(en)
|
2012-06-27 |
2015-02-27 |
Hoffmann La Roche |
MEANS AND METHODS APPLYING sFlt-1/PlGF OR ENDOGLIN/PlGF RATIO TO RULE-OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD
|
|
WO2014036440A2
(en)
|
2012-08-30 |
2014-03-06 |
Ansh Labs Llc |
Papp-a2 as a marker for monitoring, predicting and diagnosing preeclampsia
|
|
EP2912458B1
(en)
|
2012-10-24 |
2018-07-18 |
NYU Winthrop Hospital |
Non-invasive biomarker to identify subjects at risk of preterm delivery
|
|
WO2014078622A1
(en)
*
|
2012-11-15 |
2014-05-22 |
The Brigham And Women's Hospital, Inc. |
Method and system for diagnosing and treating preeclampsia
|
|
US20160025738A1
(en)
*
|
2013-03-04 |
2016-01-28 |
Iq Products B.V. |
Prognostic marker to determine the risk for early-onset preeclampsia
|
|
ES2841739T3
(es)
*
|
2013-12-03 |
2021-07-09 |
Cezanne S A S |
Método para la determinación selectiva del factor de crecimiento placental 2
|
|
WO2015110624A1
(en)
|
2014-01-24 |
2015-07-30 |
Roche Diagnostics Gmbh |
Prediction of postpartum hellp syndrome, postpartum eclampsia or postpartum preeclampsia
|
|
WO2015148989A1
(en)
|
2014-03-27 |
2015-10-01 |
Wayne State University |
Systems and methods to identify and treat subjects at risk for obstetrical complications
|
|
WO2016019176A1
(en)
|
2014-07-30 |
2016-02-04 |
Matthew Cooper |
Methods and compositions for diagnosing, prognosing, and confirming preeclampsia
|
|
WO2016132136A1
(en)
*
|
2015-02-18 |
2016-08-25 |
Aston University |
Diagnostic assay and treatment for preeclampsia
|
|
WO2016134324A1
(en)
|
2015-02-20 |
2016-08-25 |
Neoteryx, Llc |
Method and apparatus for acquiring blood for testing
|
|
WO2016149759A1
(en)
|
2015-03-23 |
2016-09-29 |
Adelaide Research & Innovation Pty Ltd |
Methods and systems for determining risk of a pregnancy complication occurring
|
|
CN108700591A
(zh)
|
2015-09-11 |
2018-10-23 |
洛斯安第斯大学 |
用于鉴定妊娠相关疾病的体外方法
|
|
NL2016967B1
(en)
|
2016-06-15 |
2017-12-21 |
Iq Products B V |
Markers and their ratio to determine the risk for early-onset preeclampsia.
|
|
US20190353667A1
(en)
|
2017-02-06 |
2019-11-21 |
Astute Medical, Inc. |
Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
|
|
KR20200109293A
(ko)
|
2017-09-13 |
2020-09-22 |
프로제너티, 인크. |
자간전증 바이오마커 및 관련된 시스템 및 방법
|